6-47478075-TAGG-T
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP6_ModerateBS1BS2
The NM_012120.3(CD2AP):c.-167_-165del variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00763 in 829,872 control chromosomes in the GnomAD database, including 27 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0064 ( 4 hom., cov: 33)
Exomes 𝑓: 0.0079 ( 23 hom. )
Consequence
CD2AP
NM_012120.3 5_prime_UTR
NM_012120.3 5_prime_UTR
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.875
Genes affected
CD2AP (HGNC:14258): (CD2 associated protein) This gene encodes a scaffolding molecule that regulates the actin cytoskeleton. The protein directly interacts with filamentous actin and a variety of cell membrane proteins through multiple actin binding sites, SH3 domains, and a proline-rich region containing binding sites for SH3 domains. The cytoplasmic protein localizes to membrane ruffles, lipid rafts, and the leading edges of cells. It is implicated in dynamic actin remodeling and membrane trafficking that occurs during receptor endocytosis and cytokinesis. Haploinsufficiency of this gene is implicated in susceptibility to glomerular disease. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP6
Variant 6-47478075-TAGG-T is Benign according to our data. Variant chr6-47478075-TAGG-T is described in ClinVar as [Likely_benign]. Clinvar id is 357159.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00638 (968/151838) while in subpopulation NFE AF= 0.00961 (652/67854). AF 95% confidence interval is 0.009. There are 4 homozygotes in gnomad4. There are 455 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 4 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD2AP | NM_012120.3 | c.-167_-165del | 5_prime_UTR_variant | 1/18 | ENST00000359314.5 | NP_036252.1 | ||
CD2AP | XM_005248976.2 | c.-167_-165del | 5_prime_UTR_variant | 1/18 | XP_005249033.1 | |||
CD2AP | XM_017010641.2 | c.-167_-165del | 5_prime_UTR_variant | 1/14 | XP_016866130.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD2AP | ENST00000359314.5 | c.-167_-165del | 5_prime_UTR_variant | 1/18 | 1 | NM_012120.3 | ENSP00000352264 | P1 | ||
CD2AP-DT | ENST00000604014.2 | n.83_85del | non_coding_transcript_exon_variant | 1/1 |
Frequencies
GnomAD3 genomes AF: 0.00639 AC: 969AN: 151718Hom.: 4 Cov.: 33
GnomAD3 genomes
AF:
AC:
969
AN:
151718
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00791 AC: 5363AN: 678034Hom.: 23 AF XY: 0.00770 AC XY: 2725AN XY: 353862
GnomAD4 exome
AF:
AC:
5363
AN:
678034
Hom.:
AF XY:
AC XY:
2725
AN XY:
353862
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00638 AC: 968AN: 151838Hom.: 4 Cov.: 33 AF XY: 0.00613 AC XY: 455AN XY: 74226
GnomAD4 genome
AF:
AC:
968
AN:
151838
Hom.:
Cov.:
33
AF XY:
AC XY:
455
AN XY:
74226
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Focal segmental glomerulosclerosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at